The life-cycles of Plasmodium species involve several different stages both in the insect and the vertebrate host. These stages include sporozoites, which are injected by the insect vector into the vertebrate host’s blood. Sporozoites infect the host liver, giving rise to merozoites and (in some species) hypnozoites. These move into the blood where they infect red blood cells. In the red blood cells, the parasites can either form more merozoites to infect more red blood cells, or produce gametocytes which are taken up by insects which feed on the vertebrate host. In the insect host, gametocytes merge to sexually reproduce. After sexual reproduction, parasites grow into new sporozoites, which move to the insect’s salivary glands, from which they can infect a vertebrate host bitten by the insect

Mumps is a viral infection that primarily affects the salivary glands, causing swelling and pain. It is most common in children, but can also affect adults who have not been vaccinated. In this case, the 10-month-old boy was exposed to another child with mumps, which raises concerns about his risk of contracting the infection.

The most appropriate management for this child would be to do nothing now but give the MMR (measles, mumps, rubella) vaccine at the appropriate age. The reason for this is that immunity against mumps takes time to develop after vaccination. By following the recommended vaccination schedule, the child will receive protection against mumps and other diseases included in the MMR vaccine.

The other options, such as assessing mumps serology or giving mumps immunoglobulin, are not necessary in this case. It is important to follow the standard vaccination guidelines to ensure the child’s long-term protection against mumps and other preventable diseases.

Initiating Antiretroviral Therapy (ART) within one week of diagnosis or linking to care is recommended for several reasons. Firstly, starting ART early can help to suppress the HIV virus quickly, reducing the viral load in the body and preventing further damage to the immune system. This can lead to better long-term health outcomes for the individual living with HIV.

Additionally, starting ART early can also help to reduce the risk of HIV transmission to others. When the viral load is suppressed, the risk of transmitting the virus to sexual partners or through sharing needles is greatly reduced.

Overall, initiating ART within one week of diagnosis or linking to care is crucial in order to improve health outcomes for individuals living with HIV and to prevent further transmission of the virus.

The most probable etiology for the 6-year-old boy’s symptoms of fever, malaise, and bloody diarrhea is Escherichia coli 0157. This particular strain of E. coli, known as enterohemorrhagic verotoxin-producing E. coli, is known to cause bloody diarrhea and can lead to complications such as hemolytic uremic syndrome.

Crohn’s disease is unlikely in this case as it typically presents with chronic symptoms rather than an acute onset. Polio and giardiasis are also less likely as they typically present with non-bloody diarrhea.

Overall, given the symptoms described, E. coli 0157 is the most probable cause of the boy’s illness.

The most likely diagnosis for this 34-year-old HIV positive man with jaundiced sclera and abnormal liver function tests is primary sclerosing cholangitis. This is because HIV can cause strictures in the biliary tract, leading to inflammation and scarring of the bile ducts. The elevated ALP and bilirubin levels, along with the presence of jaundiced sclera, are consistent with this diagnosis.

Sclerosing cholangitis is a chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to obstruction of bile flow. This can result in symptoms such as jaundice, fatigue, and itching. The liver function tests in this case show elevated ALP and bilirubin levels, which are indicative of cholestasis (impaired bile flow).

While other conditions such as hepatic abscess, fungal obstruction of the bile duct, duodenal adenoma, and primary biliary cirrhosis can also present with jaundice and abnormal liver function tests, the association of HIV with strictures in the biliary tract makes primary sclerosing cholangitis the most likely diagnosis in this case. It is important to consider the patient’s HIV status and the potential complications associated with the disease when making a diagnosis.

The most appropriate next step in this scenario would be to provide symptomatic relief for the child’s chickenpox symptoms. Chickenpox is a viral infection that typically presents with fever and multiple vesicles on the skin. The recommended treatment for chickenpox includes antihistamines to help with itching, calamine lotion to soothe the skin, and acetaminophen to reduce fever.

Oral acyclovir is not typically used for the treatment of chickenpox in otherwise healthy children, as the infection usually resolves on its own without the need for antiviral medication. Oral antibiotics would not be indicated in this case, as chickenpox is caused by a virus, not bacteria. Topical steroids may be used in some cases to help with itching, but they are not typically the first line of treatment for chickenpox.

Overall, the focus of treatment for chickenpox is on providing comfort and relief from symptoms, rather than targeting the virus itself. It is important to monitor the child’s symptoms and seek medical attention if there are any concerning signs or complications.

TB preventive therapy (TPT) is recommended for pregnant women who are at high risk of developing active TB, as it can help prevent the disease from developing.

The recommended duration of TPT for pregnant women is 6 months. This duration is based on research and clinical trials that have shown that a 6-month course of TPT is effective in reducing the risk of developing active TB in pregnant women. Additionally, a 6-month course is generally well-tolerated and safe for both the mother and the baby.

Hepatitis A is an acute viral infection that primarily affects the liver. In most cases, the infection resolves on its own within a few weeks to a couple of months. The liver biopsy done after 6 months in a patient who has clinically resolved from hepatitis A would typically show normal architecture. This is because hepatitis A does not typically lead to long-term liver damage or scarring.

Central necrosis, Mallory bodies, lobular fibrosis, and periportal fibrosis are all findings that are more commonly associated with chronic liver diseases such as hepatitis B or hepatitis C. In the case of hepatitis A, the liver is able to regenerate and repair itself after the acute infection has cleared, leading to a return to normal liver architecture.

Therefore, in this scenario, the liver biopsy done after 6 months would show normal hepatocellular architecture, indicating that the patient has fully recovered from the acute hepatitis A infection.

When a client presents without a transfer letter and reports running out of treatment, it is important to verify their treatment history with the previous facility. This is crucial for ensuring that the client receives appropriate and continuous care, as well as for understanding their current medication regimen and any potential risks or concerns.

Refusing to provide medication until a transfer letter is obtained may leave the client without necessary treatment and could potentially worsen their condition. Providing a full month’s supply of medication without verifying the treatment history may not be in the best interest of the client, as it could lead to inappropriate medication management.

Referring the client to another facility for treatment may be an option, but it is important to first verify their treatment history to ensure a smooth transition of care. Discontinuing treatment until further notice may also not be ideal, as it could leave the client without necessary medication.

Therefore, contacting the previous facility to verify the client’s treatment history is the most appropriate course of action in this situation. This allows for a comprehensive understanding of the client’s treatment needs and ensures that they receive the appropriate care moving forward.

Congenital Cytomegalovirus (CMV) infection is a common viral infection that can be passed from mother to baby during pregnancy. It is estimated that CMV affects about 1 in 150 pregnancies. Of those pregnancies affected by CMV, about 30% will transmit the virus to the fetus. And of those fetuses that are infected with CMV, about 30% will show symptoms of the infection.

Therefore, out of 200 pregnancies, 1 will be affected by CMV. Out of those affected pregnancies, 30% will transmit the virus to the fetus, resulting in about 0.3 fetuses being infected. And out of those infected fetuses, about 30% will show symptoms of the infection, resulting in about 0.09 fetuses being affected.

So, the overall likelihood of a fetus being affected by congenital CMV infection is about 1 in 1500 pregnancies.

Infants born to mothers with TB are at a higher risk of contracting TB themselves due to exposure during pregnancy or childbirth. Therefore, it is recommended to start TB preventive therapy (TPT) for these infants to reduce the risk of developing active TB disease. BCG vaccination is also recommended for infants born to mothers with TB as it can provide some protection against severe forms of TB in children.

Initiating ART immediately is not necessary for infants born to mothers with TB unless they are also HIV-positive. Discontinuing breastfeeding is not recommended as breastfeeding provides important nutrients and antibodies that can help protect the infant from infections. Conducting a sputum culture test is not necessary for infants born to mothers with TB unless they are showing symptoms of TB. Administering high-dose vitamin supplementation is not specifically recommended for infants born to mothers with TB unless there is a specific deficiency identified.

In conclusion, the recommended approach for infants born to mothers with TB is to start TB preventive therapy (TPT) and administer BCG vaccination to reduce the risk of developing active TB disease.

Understanding Pneumocystis Jirovecii Pneumonia (PJP)

Pneumocystis jirovecii pneumonia (PJP) is a fungal infection that primarily affects individuals with weakened immune systems. It is commonly seen in HIV patients with a CD4 count of less than 200, but can also occur in other immunosuppressive states. Symptoms include fever, dry cough, and progressive shortness of breath. Diagnosis can be challenging, and a high level of suspicion is required. While an abnormal chest radiograph is present in 90% of patients, blood culture is not a reliable diagnostic tool as pneumocystis cannot be cultured. Treatment involves the use of co-trimoxazole or pentamidine. Prophylaxis against PJP is recommended when CD4 counts fall below 200 cells/µl. It is important to note that while PJP is more common in HIV patients, it can also occur in individuals with other immunocompromising conditions.

Tenofovir (TDF) is an antiretroviral medication commonly used to treat HIV and hepatitis B. One of the main side effects associated with Tenofovir is kidney injury. This can manifest as decreased kidney function, proteinuria, and even acute kidney failure in severe cases. It is important for healthcare providers to monitor kidney function regularly in patients taking Tenofovir to detect any signs of kidney injury early on.

Other side effects of Tenofovir include bone loss, which can lead to osteoporosis or fractures, and Fanconi syndrome, a rare disorder that affects the kidneys’ ability to reabsorb certain substances. It is important for patients to be aware of these potential side effects and to report any symptoms to their healthcare provider promptly.

In conclusion, while Tenofovir is an effective medication for treating HIV and hepatitis B, it is important to be aware of the potential side effects, particularly kidney injury, and to monitor for any signs of these side effects during treatment.

Common Causes of Diarrhoea in Immunocompromised Patients

Immunocompromised patients, particularly those with HIV infection, are at increased risk of developing chronic diarrhoea. Among the causative organisms, Cryptosporidium is the most commonly isolated. This intracellular protozoan parasite can cause severe debilitating diarrhoea with weight loss and malabsorption in HIV-infected patients. Treatment involves fluid rehydration, electrolyte correction, and pain management, with the initiation of highly active antiretroviral therapy (HAART) being crucial for restoring immunity.

Salmonella, Isospora belli, Campylobacter, and Shigella are other common causes of diarrhoea in immunosuppressed patients. Salmonella infection typically occurs after eating uncooked foods such as chicken, while Isospora species can also cause diarrhoea but not as commonly as Cryptosporidium. Campylobacter infection can present with a flu-like prodrome, fever, and in severe cases, bloody diarrhoea and severe colitis. Treatment often involves quinolones, but one complication to be wary of is the subsequent development of neurological symptoms due to Guillain–Barré syndrome. Shigella infection typically presents with bloody diarrhoea after ingestion of the toxin.

When a pregnant mother is diagnosed with drug-resistant TB, it is crucial to seek guidance from an expert or healthcare provider due to the complexity of the situation. Drug-resistant TB requires specialized treatment and management, especially in the case of a pregnant woman where the health of both the mother and the unborn child must be considered.

Starting TB preventive therapy immediately may not be sufficient in the case of drug-resistant TB, as the treatment regimen needs to be tailored to the specific drug resistance profile of the bacteria. Initiating ART without delay is important for managing HIV infection in pregnant women, but it may not address the drug-resistant TB infection.

Referring the mother to a virologist or calling the HIV hotline may not be the most appropriate actions in this situation, as the primary concern is the management of the drug-resistant TB infection. Therefore, discussing the case with an expert or healthcare provider who has experience in treating drug-resistant TB in pregnant women is the recommended course of action. This will ensure that the mother receives the most appropriate and effective treatment to protect both her health and the health of her unborn child.

Pneumocystis Pneumonia is a common opportunistic infection in individuals with HIV, particularly those with low CD4 counts. The symptoms of Pneumocystis Pneumonia include a dry cough, shortness of breath, fatigue, and fever. The fact that the patient has a low CD4 count of 25 cells/ul indicates severe immunosuppression, putting her at high risk for opportunistic infections like Pneumocystis Pneumonia. Additionally, the 3-week history of symptoms is consistent with the typical progression of Pneumocystis Pneumonia in HIV-positive individuals.

It is important for this patient to be promptly diagnosed and treated for Pneumocystis Pneumonia, as it can be a life-threatening infection in individuals with compromised immune systems. Treatment typically involves antibiotics such as trimethoprim-sulfamethoxazole (TMP-SMX) and corticosteroids. Additionally, initiation of antiretroviral therapy (ART) is crucial to improve the patient’s immune function and prevent future opportunistic infections.

In the context of ART management, a dispensing cycle (DC) refers to the number of days for which a client receives treatment in a single standard monthly dosage. This means that if a client is prescribed a certain number of tablets to last them for a month, the dispensing cycle would be the number of days covered by that quantity of tablets.

The other options provided in the question do not accurately define a dispensing cycle in the context of ART management. The number of clinic visits per month, the time between two viral load tests, the interval between the initiation and the first revision of the ART regimen, and the waiting period for ART initiation after HIV diagnosis are all important aspects of ART management, but they do not specifically relate to the concept of a dispensing cycle.

Dolutegravir (DTG) belongs to the drug class known as Integrase Strand Transfer Inhibitors (InSTI). This class of drugs works by blocking the action of the enzyme integrase, which is responsible for inserting the viral DNA into the host cell’s DNA. By inhibiting this process, InSTIs prevent the virus from replicating and spreading throughout the body.

Protease Inhibitors, Non-nucleoside Reverse Transcriptase Inhibitors, and Nucleoside Reverse Transcriptase Inhibitors are other classes of drugs used in antiretroviral therapy (ART) for the treatment of HIV. However, Dolutegravir specifically belongs to the InSTI class.

The question is asking which of the listed options is NOT considered an antenatal risk factor for referral to a community health worker (CHW).

Teenage pregnancy, low birth weight baby, any maternal problem during or post-delivery, and substance use (tobacco, drugs, alcohol) are all commonly recognized antenatal risk factors that may warrant referral to a CHW for additional support and care.

Having a previous history of depression or anxiety is not specifically mentioned as an antenatal risk factor for referral to a CHW in the text. While mental health issues can certainly impact pregnancy and should be addressed, they may not always be included in the initial list of risk factors for referral to a CHW.

Therefore, the correct answer is: Having a previous history of depression or anxiety.

Differential Diagnosis for a Subacute Presentation of Pulmonary Symptoms

Tuberculosis is a growing concern, particularly in Eastern European countries where multi-drug resistant strains are on the rise. The initial infection can occur anywhere in the body, but often affects the lung apices and forms a scarred granuloma. Latent bacteria can cause reinfection years later, leading to post-primary TB. Diagnosis is based on identifying acid-fast bacilli in sputum. Treatment involves a 6-month regimen of antibiotics. Staphylococcal and Klebsiella pneumonia can also present with pneumonia symptoms and cavitating lesions, but patients would be expected to be very ill with signs of sepsis. Squamous cell bronchial carcinoma is a possibility but less likely in this case. Primary pulmonary lymphoma is rare and typically occurs in HIV positive individuals, with atypical presentation and radiographic findings. Contact screening is essential for TB.

Chancroid is a sexually transmitted infection caused by the bacterium Haemophilus ducreyi. It typically presents as painful genital ulcers that can bleed and have a characteristic appearance. In this case, the 4cm bleeding ulcer on the woman’s labia minora is likely due to chancroid.

When a chancroid ulcer is present, it can drain to the lymph nodes in the groin region. The lymph nodes that are most commonly affected in this case are the superficial inguinal lymph nodes. These nodes are located in the groin area and are responsible for draining lymphatic fluid from the lower extremities, external genitalia, and perineum.

Therefore, in this scenario, the bleeding ulcer on the woman’s labia minora would likely drain to the superficial inguinal lymph nodes. It is important to consider the possibility of chancroid in sexually active individuals presenting with genital ulcers, as prompt diagnosis and treatment are essential to prevent complications and further spread of the infection.

Creutzfeldt–Jakob disease = consuming beef or beef products.
Brucellosis = ingestion of unpasteurized milk or undercooked meat from infected animals.
Leptospirosis is transmitted by both wild and domestic animals. The most common animals that spread the disease are rodents.
Lyme disease is transmitted to humans by the bite of infected ticks of the Ixodes genus.
Leishmaniasis is a disease caused by protozoan parasites of the genus Leishmania and spread by the bite of certain types of sandflies.

Trimethoprim is an antibiotic that works by inhibiting the bacterial enzyme dihydrofolate reductase. This enzyme is essential for the reduction of dihydrofolic acid (DHF) to tetrahydrofolic acid (THF), which is a crucial precursor in the synthesis of thymidine, a component of DNA. By blocking this enzyme, Trimethoprim disrupts the production of THF, leading to a decrease in DNA synthesis and ultimately inhibiting bacterial growth. Therefore, the correct mechanism of action for Trimethoprim is to inhibit Folic Acid metabolism.

Tuberculosis (TB) is a bacterial infection that primarily affects the lungs but can also affect other parts of the body. Common symptoms of TB in adults and adolescents include a persistent cough of 2 weeks or more, fever for more than two weeks, drenching night sweats, chest pain and discomfort, and unexplained weight loss.

Unexplained weight gain is NOT a common symptom of tuberculosis. In fact, unexplained weight loss is more commonly associated with TB as the infection can cause a loss of appetite and difficulty in absorbing nutrients from food. Weight gain is not typically seen in individuals with TB unless they are actively trying to gain weight through diet and exercise.

Therefore, the correct answer is: Unexplained weight gain.

Resistance testing is crucial in clients failing a first-line antiretroviral therapy (ART) regimen because it helps clinicians understand why the current treatment is not working effectively. By identifying mutations associated with drug resistance, healthcare providers can make informed decisions about switching to a different combination of antiretroviral drugs that will be more effective in suppressing the virus.

Confirming the diagnosis of HIV, determining the patient’s CD4 count, assessing liver function, and monitoring for signs of lipodystrophy are all important aspects of managing HIV infection, but they are not the primary goal of resistance testing in clients failing a first-line ART regimen. The main focus of resistance testing in this context is to identify mutations that are causing the treatment to fail, so that appropriate adjustments can be made to improve the patient’s response to therapy.

Screening for tuberculosis (TB) and other opportunistic infections (OIs) is crucial for clients on antiretroviral therapy (ART) because they have weakened immune systems due to HIV infection. By conducting screening every 6 months, healthcare providers can detect infections early before they progress and cause serious complications. This regular screening helps in initiating prompt treatment, reducing the risk of transmission to others, and improving the overall health outcomes of clients on ART.

Annual screening may not be frequent enough to detect infections early, especially in clients with compromised immune systems. Waiting for symptoms to appear before conducting screening can delay diagnosis and treatment, leading to poorer outcomes. Therefore, conducting screening every 6 months strikes a balance between detecting infections early and minimizing unnecessary testing.

Streptomycin is known to have potential neurological side effects, with vestibular damage being the most common. Vestibular damage can lead to symptoms such as vertigo and vomiting. This is important to monitor in patients being treated with streptomycin, as it can significantly impact their quality of life. Cochlear damage is another possible side effect, which can result in deafness. It is important for healthcare providers to be aware of these potential side effects and monitor patients closely during treatment. Other side effects of streptomycin include rashes, angioneurotic edema, and nephrotoxicity. Overall, the benefits of treating multidrug resistant tuberculosis with streptomycin must be weighed against the potential risks of these neurological side effects.

Endogenous transmission refers to the spread of infection by organisms that are normally present in the body but have become pathogenic due to certain conditions. This type of transmission occurs when the body’s own flora, which are usually harmless, gain access to a different part of the body where they can cause infection.

In contrast, exogenous transmission involves the introduction of pathogens from external sources. For example, inhalation of secretions containing a pathogen, direct person-to-person spread, transfer due to poor hygiene and contaminated food, and transfer from pets or other animals are all examples of exogenous infections.

Therefore, the statement Commensal flora that gain access to an inappropriate area best describes endogenous transmission, as it involves the activation of normally harmless flora within the body.

Tetanus is a bacterial infection that can be caused by a puncture wound or cut contaminated with the bacteria Clostridium tetani. In this case, the 16-year-old male sustained a cut to his left shin from a sharp wooden splinter while playing football.

The most suitable management step in relation to tetanus prevention for this individual is No action is required. This is because his immunisation history is up to date, meaning he has likely received the tetanus vaccine as part of his routine childhood vaccinations.

Neonates born to HIV-positive mothers are at risk of acquiring the virus during childbirth or through breastfeeding. To prevent mother-to-child transmission of HIV, it is crucial to provide antiretroviral therapy (ART) to these neonates as soon as possible after birth.

For neonates born to HIV-positive mothers from birth to less than 4 weeks of age and weighing ≥ 3.0 kg, the recommended ART regimen is Zidovudine (AZT) + Lamivudine (3TC) + Nevirapine (NVP). This combination of antiretroviral drugs has been shown to be effective in reducing the risk of HIV transmission from mother to child.

Zidovudine (AZT) and Lamivudine (3TC) are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the replication of the HIV virus. Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that also helps to prevent the virus from multiplying in the body.

By starting ART early in neonates born to HIV-positive mothers, healthcare providers can significantly reduce the risk of HIV transmission and improve the long-term health outcomes of these infants. It is important for healthcare providers to closely monitor the neonates on this ART regimen and adjust the treatment as needed based on their individual health status.